A recent study by Fang et al. found that HSP90α expressions were positively correlated with tumor–node–metastasis staging in patients with lung adenocarcinoma and suggested combining HSP90α with carcinoembryonic antigen for more effective prediction of patient prognosis [226]. This evidence concerns the gene CEACAM5 and neoplasm.